Patient Engagement Strategies Include Core Compensation Principles

The International Society for Pharmacoeconomics and Outcomes Research recently published its May/July issue of its Value & Outcomes Spotlight journal featuring an article on successfully recruiting and compensating patients in research studies. Although many regulatory bodies, including the Food and Drug Administration, have expressed interest in including patients throughout the drug development pipeline, patient compensation continues to perplex healthcare stakeholders. The article discusses when it’s appropriate to offer compensation, such as when patients must travel to participate in a clinical trial.

The authors note, “Patient engagement in health-related research has become a mainstay over the past decade, recognized and promulgated by government, industry, and, of course, patients themselves,” adding, “The principles provided the foundation for the compensation toolbox and guided considerations on such things as what to do when someone declines compensation, or when engaging a celebrity patient, how travel expenses should be reimbursed, and other similar issues.” Read more here.

(Eleanor Perfetto, Silke Schoch, Elisabeth Oehrlein, Value & Outcomes Spotlight, ISPOR, 5/2021)